Dan Worthley, a co-author of the study, emphasized that the true potential of this technology extends beyond disease detection. In an article for The Conversation, Worthley underscored the prospects of utilizing cellular healthcare for targeted biological therapy. This futuristic concept involves deploying treatment precisely to specific regions of the body based on the presence of distinctive DNA sequences.
